RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.

Clinical trial NCT01805921 · COMPLETED

Trial details

NCT number: NCT01805921
Sponsor: ReiThera Srl
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2013-05-01
Primary completion: 2015-08-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.